Correlations Between TET2 Mutation and Clinicohematologic Parameters in Myeloproliferative Neoplasms

被引：0
|
作者：
Ha, Jung Sook [1 ]
Lee, Jae Hee [1 ]
Park, Sung Gyun [1 ]
Ryoo, Nam Hee [1 ]
Jeon, Dong Suk [2 ]
Kim, Jae Ryong [2 ]
Do, Young Rok [3 ]
Kim, Jin Young [4 ]
Kwon, Ki Young [5 ]
Kim, Ji Yoon [6 ]
Suh, Jang Soo [7 ]
机构：
[1] Keimyung Univ, Sch Med, Dept Lab Med, Taegu, South Korea
[2] Keimyung Univ, Sch Medice, Dept Lab Med, Taegu, South Korea
[3] Keimyung Univ, Sch Med, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea
[4] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Hemato Oncol, Taegu, South Korea
[5] Keimyung Univ, Sch Medine, Dept Internal Med, Div Hematol Oncol, Taegu, South Korea
[6] Keimyung Univ, Sch Medice, Dept Pediat Hematol Oncol, Taegu, South Korea
[7] Kyungpook Natl Univ Hosp, Taegu, South Korea
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1455.1455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1455
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Role of TET2 Mutations in Myeloproliferative Neoplasms
    Elodie Pronier
    François Delhommeau
    Current Hematologic Malignancy Reports, 2012, 7 : 57 - 64
  • [2] Role of TET2 Mutations in Myeloproliferative Neoplasms
    Pronier, Elodie
    Delhommeau, Francois
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (01) : 57 - 64
  • [3] Analysis of the Ten-Eleven Translocation 2 (TET2) Gene Mutation in Myeloproliferative Neoplasms
    Ha, Jung-Sook
    Jeon, Dong-Seok
    Kim, Jae-Ryong
    Ryoo, Nam-Hee
    Suh, Jang-Soo
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2014, 44 (02): : 173 - 179
  • [4] Correlations between Janus Kinase 2 V617F Allele Burdens and Clinicohematologic Parameters in Myeloproliferative Neoplasms
    Ha, Jung-Sook
    Kim, Yu-Kyung
    Jung, Soon-Il
    Jung, He-Ra
    Chung, In-Sung
    ANNALS OF LABORATORY MEDICINE, 2012, 32 (06) : 385 - 391
  • [5] Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms
    Hussein, Kebede
    Abdel-Wahab, Omar
    Lasho, Terra L.
    Van Dyke, Daniel L.
    Levine, Ross L.
    Hanson, Curtis A.
    Pardanani, Animesh
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (01) : 81 - 83
  • [6] The Role of TET2 Mutation in Patients with Myeloproliferative Neoplasms and Thrombosis in Unusual Sites (Splanchnic Thrombosis and Cerebral Thrombosis)
    Morsia, Erika
    Ranalli, Paola
    Baldoni, Stefano
    Lame, Dorela
    More', Sonia
    La Barba, Gaetano
    Saladino, Fabiola
    Poloni, Antonella
    Olivieri, Attilio
    Rupoli, Serena
    Di Ianni, Mauro
    Kordasti, Shahram
    BLOOD, 2024, 144 : 6645 - 6645
  • [7] Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
    Schaub, Franz X.
    Looser, Renate
    Li, Sai
    Hui Hao-Shen
    Lehmann, Thomas
    Tichelli, Andre
    Skoda, Radek C.
    BLOOD, 2010, 115 (10) : 2003 - 2007
  • [8] Role of TET2 and ASXL1 Mutations in the Pathogenesis of Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Mu, Ayalew Tefferi
    Levine, Ross L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) : 1053 - +
  • [9] TET2 Mutations in a Cohort of Patients with Myeloproliferative Neoplasms Lacking a Molecular Marker
    Maria Martinez-Aviles, Luz
    Besses, Carlos
    Alvarez-Larran, Alberto
    Pons, Aina
    Serrano, Sergi
    Bellosillo, Beatriz
    BLOOD, 2009, 114 (22) : 1504 - 1505
  • [10] Methylation of TET2, CBL and CEBPA in Ph-negative myeloproliferative neoplasms
    Chim, C. S.
    Wan, T. S.
    Fung, T. K.
    Wong, K. F.
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (10) : 942 - 946
12345